Oral Vancomycin and Gentamicin for Treatment of Very Early Onset Inflammatory Bowel Disease.
10.1159/000475660
Saved in:
Main Authors: | Lev-Tzion, Raffi, Ledder, Oren, Shteyer, Eyal, TAN LI NIEN, Uhlig, Holm H, Turner, Dan |
---|---|
Other Authors: | PAEDIATRICS |
Format: | Article |
Published: |
S. Karger AG
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/207496 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Health-related quality of life of patients with inflammatory bowel disease in Singapore
by: Ho, P.Y.M., et al.
Published: (2021) -
Pediatric Inflammatory Bowel Disease in Asia: Epidemiology and natural history
by: Huang, J.G., et al.
Published: (2021) -
Intraperitoneal vancomycin/oral pefloxacin versus intraperitoneal vancomycin/gentamicin in the treatment of continuous ambulatory peritoneal dialysis peritonitis
by: Lye, W.-C., et al.
Published: (2016) -
Characteristics and outcome of primary sclerosing cholangitis associated with inflammatory bowel disease in Asian children
by: Lee, Way Seah, et al.
Published: (2021) -
Colonic mucosal microbiota and association of bacterial taxa with the expression of host antimicrobial peptides in pediatric ulcerative colitis
by: Jalanka, Jonna, et al.
Published: (2021)